Tonghua Dongbao Pharmaceutical Co., Ltd. (600867) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Tonghua Dongbao Pharmaceutical Co., Ltd.

Why is Tonghua Dongbao Pharmaceutical Co., Ltd. ?

With a growth in Net Sales of 11.18%, the company declared Very Positive results in Mar 25

The company has declared positive results in Jan 70 after 5 consecutive negative quarters
PRE-TAX PROFIT(Q) At CNY 87.96 MM has Grown at 232.09%
NET PROFIT(Q) At CNY 109.53 MM has Grown at 1,115.99%
NET SALES(Q) At CNY 646.89 MM has Grown at 29.67%

With ROE of 6.45%, it has a fair valuation with a 2.66 Price to Book Value

Over the past year, while the stock has generated a return of 3.30%, its profits have fallen by -12.5%
At the current price, the company has a high dividend yield of 3.1

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Tonghua Dongbao Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Tonghua Dongbao Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Tonghua Dongbao Pharmaceutical Co., Ltd.

3.3%

-0.14

22.10%

China Shanghai Composite

14.77%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-1.27%

EBIT Growth (5y)

-19.10%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

0.01

Sales to Capital Employed (avg)

0.36

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

17.69%

ROE (avg)

17.19%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.66

EV to EBIT

48.39

EV to EBITDA

26.90

EV to Capital Employed

2.75

EV to Sales

6.07

PEG Ratio

Dividend Yield

3.06%

ROCE (Latest)

5.68%

ROE (Latest)

6.45%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

PRE-TAX PROFIT(Q)

At CNY 87.96 MM has Grown at 232.09%

NET PROFIT(Q)

At CNY 109.53 MM has Grown at 1,115.99%

NET SALES(Q)

At CNY 646.89 MM has Grown at 29.67%

-32What is not working for the Company

NET SALES(HY)

At CNY 1,203.79 MM has Grown at -23.23%

NET PROFIT(HY)

At CNY 132.78 MM has Grown at -78.63%

OPERATING CASH FLOW(Y)

Lowest at CNY 438.54 MM

ROCE(HY)

Lowest at -2.13%

INTEREST(Q)

At CNY 5.26 MM has Grown at 13.58%

RAW MATERIAL COST(Y)

Grown by 6.55% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.87%

Here's what is working for Tonghua Dongbao Pharmaceutical Co., Ltd.

Pre-Tax Profit

At CNY 87.96 MM has Grown at 232.09%

over average net sales of the previous four periods of CNY -66.59 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 109.53 MM has Grown at 1,115.99%

over average net sales of the previous four periods of CNY -10.78 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Net Sales

At CNY 646.89 MM has Grown at 29.67%

over average net sales of the previous four periods of CNY 498.86 MM

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Here's what is not working for Tonghua Dongbao Pharmaceutical Co., Ltd.

Interest

At CNY 5.26 MM has Grown at 13.58%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow

Lowest at CNY 438.54 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest

Highest at CNY 5.26 MM

in the last five periods and Increased by 13.58% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debtors Turnover Ratio

Lowest at 2.87%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 6.55% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales